Value of lipopolysaccharide binding protein, interleukin-6 and C-reactive protein as biomarkers of severity in acute diverticulitis : a prospective study / Christoph Elsing, Susanne Ernst, Wolfgang Stremmel
BACKGROUND: New biomarkers have the capability to predict severity and outcome of infectious diseases. Lipopolysaccharide binding protein (LBP) and Interleukin 6 (IL-6) were determined as new markers in patients with acute diverticulitis and were compared with standard markers such as C-reactive protein (CRP) and white blood cell count (WBC). - METHODS: CRP, IL-6, WBC and LBP were measured in 38 patients at hospital admission and every second day and after colonoscopy. Multi-slice CT scans, ultrasound and early colonoscopy were performed to confirm diagnosis and to detect complications (perforations, stenosis). - RESULTS: CRP, IL-6 and LBP levels one correlated highly with each other and were equally influenced by antibiotic therapy. WBC changes were unremarkable. Severity of the disease (sealed- or non-perforation) was not reflected by the biomarkers. In non-perforated patients, colonoscopy was performed on day 6 (median) after admission with a success rate of 93%. Sealed-perforated patients were examined on median day 11 with a success rate of 60% (p > 0.001). Failure in all cases was due to sigmoidal stenosis requiring surgery. In a receiver-operating characteristic curve analysis (ROC), LBP on day one performed best in predicting colonic steno-sis with an area under the curve of 0.88 (95% CI 0.73 - 0.03 p < 0.02). - CONCLUSIONS: CRP, IL-6, and LBP can be used to monitor diverticulitis. Initial LBP values in patients with acute diverticulitis may also be usefully in detecting candidates for surgical intervention..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
January 2012 2012 |
---|---|
Erschienen: |
January 2012 |
Enthalten in: |
Zur Gesamtaufnahme - volume:58 |
---|---|
Enthalten in: |
Clinical laboratory - 58(2012), 1/2, Seite 145-151 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Elsing, Christoph [VerfasserIn] |
---|
Anmerkungen: |
Gesehen am 11.07.2019 |
---|
Umfang: |
7 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
1669053636 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | 1669053636 | ||
003 | DE-627 | ||
005 | 20230428192206.0 | ||
007 | cr uuu---uuuuu | ||
008 | 190711s2012 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)1669053636 | ||
035 | |a (DE-599)KXP1669053636 | ||
035 | |a (OCoLC)1341233585 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
100 | 1 | |a Elsing, Christoph |e verfasserin |0 (DE-588)1094917478 |0 (DE-627)855376422 |0 (DE-576)166162914 |4 aut | |
245 | 1 | 0 | |a Value of lipopolysaccharide binding protein, interleukin-6 and C-reactive protein as biomarkers of severity in acute diverticulitis |b a prospective study |c Christoph Elsing, Susanne Ernst, Wolfgang Stremmel |
264 | 1 | |c January 2012 | |
300 | |a 7 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Gesehen am 11.07.2019 | ||
520 | |a BACKGROUND: New biomarkers have the capability to predict severity and outcome of infectious diseases. Lipopolysaccharide binding protein (LBP) and Interleukin 6 (IL-6) were determined as new markers in patients with acute diverticulitis and were compared with standard markers such as C-reactive protein (CRP) and white blood cell count (WBC). - METHODS: CRP, IL-6, WBC and LBP were measured in 38 patients at hospital admission and every second day and after colonoscopy. Multi-slice CT scans, ultrasound and early colonoscopy were performed to confirm diagnosis and to detect complications (perforations, stenosis). - RESULTS: CRP, IL-6 and LBP levels one correlated highly with each other and were equally influenced by antibiotic therapy. WBC changes were unremarkable. Severity of the disease (sealed- or non-perforation) was not reflected by the biomarkers. In non-perforated patients, colonoscopy was performed on day 6 (median) after admission with a success rate of 93%. Sealed-perforated patients were examined on median day 11 with a success rate of 60% (p > 0.001). Failure in all cases was due to sigmoidal stenosis requiring surgery. In a receiver-operating characteristic curve analysis (ROC), LBP on day one performed best in predicting colonic steno-sis with an area under the curve of 0.88 (95% CI 0.73 - 0.03 p < 0.02). - CONCLUSIONS: CRP, IL-6, and LBP can be used to monitor diverticulitis. Initial LBP values in patients with acute diverticulitis may also be usefully in detecting candidates for surgical intervention. | ||
650 | 4 | |a Acute Disease | |
650 | 4 | |a Acute-Phase Proteins | |
650 | 4 | |a Anti-Bacterial Agents | |
650 | 4 | |a C-Reactive Protein | |
650 | 4 | |a Carrier Proteins | |
650 | 4 | |a Colonoscopy | |
650 | 4 | |a Diverticulitis, Colonic | |
650 | 4 | |a Female | |
650 | 4 | |a Humans | |
650 | 4 | |a Interleukin-6 | |
650 | 4 | |a Male | |
650 | 4 | |a Membrane Glycoproteins | |
650 | 4 | |a Middle Aged | |
650 | 4 | |a Monitoring, Physiologic | |
650 | 4 | |a Prognosis | |
650 | 4 | |a Prospective Studies | |
650 | 4 | |a ROC Curve | |
700 | 1 | |a Ernst, Susanne |e verfasserin |0 (DE-588)1190334429 |0 (DE-627)1669053881 |4 aut | |
700 | 1 | |a Stremmel, Wolfgang |d 1952- |e verfasserin |0 (DE-588)142773638 |0 (DE-627)640118747 |0 (DE-576)33331560X |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical laboratory |d Heidelberg : Clin Lab Publ., Verl. Klinisches Labor, 1992 |g 58(2012), 1/2, Seite 145-151 |h Online-Ressource |w (DE-627)592072312 |w (DE-600)2479711-X |w (DE-576)339571489 |7 nnns |
773 | 1 | 8 | |g volume:58 |g year:2012 |g number:1/2 |g pages:145-151 |g extent:7 |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ILN_2013 | ||
912 | |a ISIL_DE-16-250 | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
912 | |a SSG-OLC-PHA | ||
936 | u | w | |d 58 |j 2012 |e 1/2 |h 145-151 |g 7 |
951 | |a AR | ||
952 | |d 58 |j 2012 |e 1/2 |h 145-151 |g 7 | ||
980 | |2 2013 |1 01 |x DE-16-250 |b 3492759947 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 11-07-19 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 00 |s s |a hd2012 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 01 |s s |0 (DE-627)1410508463 |a wissenschaftlicher Artikel (Zeitschrift) | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 02 |s s |a per_3 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 03 |s s |a s_7 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s p |0 (DE-627)1532862776 |a Elsing, Christoph | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s k |0 (DE-627)1416822720 |a Extern | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |a pos_1 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s p |0 (DE-627)1669053911 |a Ernst, Susanne | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s k |0 (DE-627)1416740783 |a Medizinische Universitätsklinik und Poliklinik | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s s |a pos_2 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s p |0 (DE-627)1436010535 |a Stremmel, Wolfgang | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s k |0 (DE-627)1416740783 |a Medizinische Universitätsklinik und Poliklinik | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s s |a pos_3 |